Joinn Laboratories H1 profit jumps 1,127% on drug demand
Joinn Laboratories reported H1 profit up 1,127% amid strong drug demand, per TradingView News.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.